Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.30 |
| ▸ | OAT | P04181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL813575 | 1.00 | TSHR (0.35) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL14030764 | 0.81 | POLB (0.33) | ALDH1A1 | |
| SCHEMBL13064987 | 0.72 | — | — | |
| SCHEMBL28281117 | 0.71 | TSHR (0.33) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL7112593 | 0.71 | TSHR (0.33) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL27723749 | 0.67 | TSHR (0.41) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL9635649 | 0.60 | CA1 (0.40) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL10964095 | 0.60 | ALOX15 (0.36) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL22362544 | 0.60 | TSHR (0.35) | TSHRTP53DAONAPRTALDH1A1 | |
| SCHEMBL8565178 | 0.60 | MAOA (0.35) | TSHRTP53DAONAPRTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8062558-B2 | Conductive paste | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-11-22 | — | — | US | claimed |
| US-5037748-A | From phthalic acid or salt using a microorganism, acidification, solvent extraction | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-08-06 | — | — | US | claimed |
| EP-0360407-A1 | Cis-4,5-dihydro-4,5-dihydroxyphthalic acid and its salts, and process for producing the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-03-28 | — | — | EP | claimed |
| JP-2149540-A | — | — | None | — | — | JP | disclosed |
| US-12516284-B2 | Separation method and enrichment culture method of pseudomonas, and remediation method for contaminated soil | Qingdao university of technology (CN) | 2026-01-06 | — | — | US | disclosed |
| US-20240060036-A1 | SEPARATION METHOD AND ENRICHMENT CULTURE METHOD OF PSEUDOMONAS, AND REMEDIATION METHOD FOR CONTAMINATED SOIL | Qingdao university of technology (CN) | 2024-02-22 | — | — | US | disclosed |
| US-20230201152-A1 | COCRYSTAL ANTIOXIDANTS OF PROTOCATECHUIC ACID WITH L-THEANINE FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY CONDITIONS | THEAPRIN PHARMACEUTICALS INC. (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230201152-A1 | COCRYSTAL ANTIOXIDANTS OF PROTOCATECHUIC ACID WITH L-THEANINE FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY CONDITIONS | THEAPRIN PHARMACEUTICALS INC. (US) | 2023-06-29 | — | — | US | disclosed |
| CN-115747067-A | Separation and enrichment culture method of pseudomonas and method for restoring polluted soil | 青岛理工大学 | 2023-03-07 | — | — | CN | disclosed |
| CN-115484867-A | Transducer, nanoparticle transducer apparatus and system, and related methods of use | 华盛顿大学 | 2022-12-16 | — | — | CN | disclosed |
| US-8241760-B2 | Joint structure, joining method, wiring board and method for producing the same | SUMITOMO BAKELITE COMPANY, LTD. (JP) | 2012-08-14 | — | — | US | disclosed |
| EP-0466793-A1 | CYCLOHEXADIENEDIOLS AND THEIR USE | ENZYMATIX LTD. (GB) | 1992-01-22 | — | — | EP | disclosed |
| US-5037748-A | From phthalic acid or salt using a microorganism, acidification, solvent extraction | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| US-5037748-A | From phthalic acid or salt using a microorganism, acidification, solvent extraction | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| US-5037748-A | From phthalic acid or salt using a microorganism, acidification, solvent extraction | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| WO-1990012798-A2 | CYCLOHEXADIENEDIOLS AND THEIR USE | ENZYMATIX LTD. (GB) | 1990-11-01 | — | — | WO | disclosed |
| JP-H02149540-A | 4,5-DIHYDRO-4,5-DIHYDROXYPHTHALIC ACID AND SALT THEREOF AND PRODUCTION THEREOF | JAPAN SYNTHETIC RUBBER CO LTD | 1990-06-08 | — | — | JP | disclosed |
| EP-0360407-A1 | Cis-4,5-dihydro-4,5-dihydroxyphthalic acid and its salts, and process for producing the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
| EP-0360407-A1 | Cis-4,5-dihydro-4,5-dihydroxyphthalic acid and its salts, and process for producing the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
| EP-0360407-A1 | Cis-4,5-dihydro-4,5-dihydroxyphthalic acid and its salts, and process for producing the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201152-A1 | COCRYSTAL ANTIOXIDANTS OF PROTOCATECHUIC ACID WITH L-THEANINE FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY CONDITIONS | PTGES, MGST3, LPO | TSHR 4762/4885TP53 1369/4885DAO 1098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.